COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Diabetes Risk Evaluation and Management Tele-monitoring Study (DREAM-Tel) (DREAM-Tel)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00325624
Recruitment Status : Completed
First Posted : May 15, 2006
Last Update Posted : May 23, 2012
Battlefords Tribal Council Indian Health Services
Information provided by (Responsible Party):
Sheldon Tobe, Sunnybrook Health Sciences Centre

Brief Summary:
The purpose behind the proposed research is that diabetes care in First Nations people can be improved by involvement of a Home Care team providing diabetes education and management, supported by emerging technology, specifically Bluetooth-enabled glucometers and blood pressure monitors, capable of transmitting their data to a web environment in tabulated and graphical format available for remote viewing.

Condition or disease Intervention/treatment Phase
Hypertension Diabetes Mellitus Device: Bluetooth-enabled Glucometer Phase 1

Detailed Description:

Diabetes mellitus is a systemic disease that produces a diverse array of complications. The pathogenesis of these complications refers back to two factors, one of which (high blood glucose) alters proteins leading to tissue and blood vessel damage, while the other (high blood pressure), exacerbates the vascular damage causing further damage to target organs. Our long term goal is to achieve targets for blood glucose and blood pressure as outlined by Clinical Practice Guidelines.

Despite current Clinical Practice Guidelines and evidence-based practice by the medical community, including family physicians and the Home Care team, blood glucose control in general and in the First Nations community specifically is not meeting targets. Poor control of blood glucose in type 2 diabetes dramatically increases the risk of heart disease, stroke, vascular limb loss, blindness, kidney disease and the need for dialysis. Control of blood glucose levels prevents these complications. Additionally, the intensification of diabetes control, including the initiation of insulin, is not easily done during a regular primary care visit. The lack of intensification of diabetes management in people with poorly controlled diabetes has been referred to as 'clinical inertia'. While subjects referred to specialists have somewhat better control of diabetes, more than 50% still failed to have intensification of diabetes management within four months of a lab report showing a high level of A1c. Multidisciplinary care can overcome clinical inertia, even in difficult practice settings. Finally, the emerging technology of Bluetooth-enabled devices and secure web-based monitoring logs allows health care providers for the first time to remotely monitor progress providing a higher level of confidence in self blood glucose monitoring (SBGM) and blood pressure results. Based on these facts, the experimental focus of this proposal is on the introduction of a Home Care Team diabetes management program that can provide intensification of diabetes management right in the patient's home, supported by the emerging technology of Bluetooth- enabled devices. The specific aims are designed to provide a comprehensive assessment of the impact of the introduction of this program.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 40 participants
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Official Title: Diabetes Risk Evaluation and Management Tele-monitoring Study (DREAM-Tel)
Study Start Date : November 2006
Actual Primary Completion Date : December 2007
Actual Study Completion Date : April 2008

Resource links provided by the National Library of Medicine

Intervention Details:
  • Device: Bluetooth-enabled Glucometer
    blood glucose information provided to health care providers

Primary Outcome Measures :
  1. A1c [ Time Frame: 1 year ]
    Change of A1c over 1 year

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Type 2 Diabetes with baseline A1c > 8.0 % on diet or medical therapy with no history of diabetic ketoacidosis.
  • Patients must be greater than or equal to 18 years of age.
  • Written informed consent must be obtained prior to admission to this study.

Exclusion Criteria:

  • Hypoglycemic therapy and A1c<8.0%
  • New York Heart Association Stage III-IV congestive heart failure. This will eliminate approximately 2% of people with diabetes based on the Strong Heart Study Data.
  • Suspected secondary hypertension due to any cause (e.g. pheochromocytoma,coarction of the aorta or renal insufficiency.)
  • Unstable angina, myocardial infarction, or revascularization within the last 3 months.
  • Angioedema.
  • Cerebrovascular event, including stroke or transient ischemic attack, within the last six months.
  • Creatinine >250 umol/L
  • Cerebral Vascular event, including strike or transient ischemic attack, within the last six months.
  • Connective tissue disorders (e.g.lupus, rheumatoid arthritis)
  • Active hepatic disease as indicated by AST and ALT >2X the upper limit of normal; serum bilirubin >1.5X upper limit of normal, or serum albumin <3.0 gm/dl.
  • Severe systemic or malignant disease(which could reasonably be expected to be fatal or life-threatening during the course of the study.)
  • Pregnancy. It is expected that some women will want to exit the study to become pregnant (5% of female enrollees).
  • Factors suggesting low likelihood of compliance with the protocol (e.g current alcohol abuse, history of unreliability in keeping appointments or taking medications.
  • Any medical condition that study physicians believe would interfere with study participation or evaluation of results.
  • Mental incapacity and/or cognitive impairment on the part of the patient that would preclude adequate understanding of, or cooperation with, the study protocol.
  • Participation in any clinical trial of any investigational medication within 3 months prior to this trial. This is unlikely because clinical trials among First Nations people are rare.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00325624

Layout table for location information
Canada, Ontario
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada, M4N 3M5
Canada, Saskatchewan
Battleford Tribal Council Indian Health Services
North Battleford, Saskatchewan, Canada, S9A 0V0
Sponsors and Collaborators
Sunnybrook Health Sciences Centre
Battlefords Tribal Council Indian Health Services
Layout table for investigator information
Principal Investigator: Sheldon W Tobe, MD, FRCPC Sunnybrook Health Sciences Centre
Principal Investigator: George Pylypchuk, MD, FRCP(C) University of Saskatchewan
Publications automatically indexed to this study by Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Sheldon Tobe, Associate Professor of Medicine, University of Toronto, Sunnybrook Health Sciences Centre Identifier: NCT00325624    
Other Study ID Numbers: 2006-04
First Posted: May 15, 2006    Key Record Dates
Last Update Posted: May 23, 2012
Last Verified: May 2012
Keywords provided by Sheldon Tobe, Sunnybrook Health Sciences Centre:
Blood Pressure
Diabetes mellitus
Home Care
Additional relevant MeSH terms:
Layout table for MeSH terms
Diabetes Mellitus
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases
Vascular Diseases
Cardiovascular Diseases